本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Erasca, INC.

1.24
+0.08006.90%
盘后1.270.0300+2.42%18:52 EDT
成交量:170.12万
成交额:220.69万
市值:3.51亿
市盈率:-1.79
高:1.42
开:1.17
低:1.13
收:1.16
数据加载中...

公司资料

公司名字:
Erasca, INC.
交易所:
NASDAQ
成立时间:
2018
员工人数:
103
公司地址:
3115 Merryfield Row,Suite 300,San Diego,California,United States
邮编:
92121
电话:
传真:
- -
简介:
Erasca, Inc.于2018年7月2日在特拉华州注册成立。该公司是一家临床阶段的精准肿瘤学公司,专注于发现、开发和商业化RAS/MAPK通路驱动癌症患者的疗法。该公司由精准肿瘤学和RAS靶向领域的领先先驱共同创立,旨在创造新的疗法和联合方案,旨在全面关闭RAS/MAPK通路以治疗癌症。

董事

名称
职位
Jonathan E. Lim
Chairman, Chief Executive Officer and Co-Founder
Michael D. Varney
Director, Chair of Research and Development and SAB member
Alexander W. Casdin
Director
Bihua Chen
Director
James A. Bristol
Director
Julie Hambleton
Director
Pratik S. Multani
Director
Valerie Harding Start
Director

股东

名称
职位
Jonathan E. Lim
Chairman, Chief Executive Officer and Co-Founder
David M. Chacko
Chief Financial Officer
Ebun S. Garner
General Counsel and Corporate Secretary
Wei Lin
Chief Medical Officer